A new machine-learning model to predict long-term renal function impairment after minimally invasive partial nephrectomy: the Fundació Puigvert predictive model.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 04 05 2023
accepted: 22 08 2023
medline: 9 11 2023
pubmed: 16 9 2023
entrez: 15 9 2023
Statut: ppublish

Résumé

To provide a new model to predict long-term renal function impairment after partial nephrectomy (PN). Data of consecutive patients who underwent minimally invasive PN from 2005 to 2022 were analyzed. A minimum of 12 months of follow-up was required. We relied on a machine-learning algorithm, namely classification and regression tree (CART), to identify the predictors and associated clusters of chronic kidney disease (CKD) stage migration during follow-up. 568 patients underwent minimally invasive PN at our center. A total of 381 patients met our inclusion criteria. The median follow-up was 69 (IQR 38-99) months. A total of 103 (27%) patients experienced CKD stage migration at last follow-up. Progression of CKD stage after surgery, ACCI and baseline CKD stage were selected as the most informative risk factors to predict CKD progression, leading to the creation of four clusters. The progression of CKD stage rates for cluster #1 (no progression of CKD stage after surgery, baseline CKD stage 1-2, ACCI 1-4), #2 (no progression of CKD stage after surgery, baseline CKD stage 1-2, ACCI ≥ 5), #3 (no progression of CKD stage after surgery and baseline CKD stage 3-4-5) and #4 (progression of CKD stage after surgery) were 6.9%, 28.2%, 37.1%, and 69.6%, respectively. The c-index of the model was 0.75. We developed a new model to predict long-term renal function impairment after PN where the perioperative loss of renal function plays a pivotal role to predict lack of functional recovery. This model could help identify patients in whom functional follow-up should be intensified to minimize possible worsening factors of renal function.

Identifiants

pubmed: 37714966
doi: 10.1007/s00345-023-04593-8
pii: 10.1007/s00345-023-04593-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2985-2990

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Ljungberg B, Albiges L, Abu-Ghanem Y et al (2022) European Association of Urology Guidelines on renal cell carcinoma: the 2022 update. Eur Urol 82(4):399–410. https://doi.org/10.1016/j.eururo.2022.03.006
doi: 10.1016/j.eururo.2022.03.006 pubmed: 35346519
Van Poppel H, Da Pozzo L, Albrecht W et al (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59(4):543–552. https://doi.org/10.1016/j.eururo.2010.12.013 . (Epub 2010 Dec 22)
doi: 10.1016/j.eururo.2010.12.013 pubmed: 21186077
MacLennan S, Imamura M, Lapitan MC, UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel et al (2012) Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol 62(6):1097–1117
doi: 10.1016/j.eururo.2012.07.028 pubmed: 22841673
Kates M, Badalato GM, Pitman M, McKiernan JM (2011) Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 186(4):1247–1253. https://doi.org/10.1016/j.juro.2011.05.054 . (Epub 2011 Aug 17)
doi: 10.1016/j.juro.2011.05.054 pubmed: 21849201
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305
doi: 10.1056/NEJMoa041031 pubmed: 15385656
Huang WC, Levey AS, Serio AM et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7(9):735–740
doi: 10.1016/S1470-2045(06)70803-8 pubmed: 16945768 pmcid: 2239298
Volpe A, Blute ML, Ficarra V et al (2015) Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 68(1):61–74
doi: 10.1016/j.eururo.2015.01.025 pubmed: 25703575
Yu YD, Nguyen NH, Ryu HY et al (2019) Predictors of renal function after open and robot-assisted partial nephrectomy: a propensity score-matched study. Int J Urol 26(3):377–384
doi: 10.1111/iju.13879 pubmed: 30582218
Bhindi B, Lohse CM, Schulte PJ et al (2019) Predicting renal function outcomes after partial and radical nephrectomy. Eur Urol 75(5):766–772
doi: 10.1016/j.eururo.2018.11.021 pubmed: 30477983
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
doi: 10.7326/0003-4819-150-9-200905050-00006 pubmed: 19414839 pmcid: 2763564
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212
doi: 10.1186/cc2872 pubmed: 15312219 pmcid: 522841
Levin A, Stevens PE, Bilous RW, Kidney disease: Improving global outcomes (KDIGO) CKD work group et al (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 3(1):1–150
Breiman L, Friedman J, Olshen R, Stone Breiman C (1984) Classification and regression trees. Chapman and Hall, Wadsworth
Xiong L, Nguyen JK, Peng Y et al (2022) What happens to the preserved renal parenchyma after clamped partial nephrectomy? Eur Urol 81(5):492–500
doi: 10.1016/j.eururo.2021.12.036 pubmed: 35058086
Bravi CA, Vertosick E, Benfante N et al (2019) Impact of acute kidney injury and its duration on long-term renal function after partial nephrectomy. Eur Urol 76(3):398–403
doi: 10.1016/j.eururo.2019.04.040 pubmed: 31080127 pmcid: 7641193
Martini A, Cumarasamy S, Beksac AT et al (2018) A nomogram to predict significant estimated glomerular filtration rate reduction after robotic partial nephrectomy. Eur Urol 74(6):833–839
doi: 10.1016/j.eururo.2018.08.037 pubmed: 30224195
Mari A, Tellini R, Antonelli A et al (2022) A nomogram for the prediction of intermediate significant renal function loss after robot-assisted partial nephrectomy for localized renal tumors: a prospective multicenter observational study (RECORd2 Project). Eur Urol Focus 8(4):980–987
doi: 10.1016/j.euf.2021.09.012 pubmed: 34561199
Pecoraro A, Campi R, Bertolo R, et al (2023) Estimating postoperative renal function after surgery for nonmetastatic renal masses: a systematic review of available prediction models. Eur Urol Oncol. S2588-9311(22)00205-X

Auteurs

Alessandro Uleri (A)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain. alessandrouleri@outlook.it.

Michael Baboudjian (M)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Andrea Gallioli (A)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Angelo Territo (A)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Josep Maria Gaya (JM)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Isabel Sanz (I)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Jorge Robalino (J)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Marta Casadevall (M)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Pietro Diana (P)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Paolo Verri (P)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Giuseppe Basile (G)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Oscar Rodriguez-Faba (O)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Antonio Rosales (A)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Joan Palou (J)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Alberto Breda (A)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH